Keysight Technologies, Inc.
KEYSNYSEIndustrials · Industrial Instruments For Measurement, Display, and Control · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $5.38B | $4.98B | $5.46B | $5.42B | $4.94B | $4.22B |
| Operating income | $876.0M | $833.0M | $1.36B | $1.33B | $1.08B | $765.0M |
| Net income | $850.0M | $614.0M | $1.06B | $1.12B | $894.0M | $627.0M |
| Total assets | $11.30B | $9.27B | $8.68B | $8.10B | $7.78B | $7.22B |
| Total liabilities | $5.42B | $4.16B | $4.03B | $3.94B | $4.00B | $3.92B |
| Equity | $5.88B | $5.11B | $4.65B | $4.16B | $3.78B | $3.30B |
| EPS (diluted) | $4.91 | $3.51 | $5.91 | $6.18 | $4.78 | $3.31 |
| Shares out. | 171.8M | 173.2M | 175.0M | 178.8M | 183.0M | 186.1M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 16.3%
- Net margin
- 15.8%
- Return on equity
- 14.5%
- Return on assets
- 7.5%
- Return on capital (ROCE)
- 9.3%
- Liabilities / assets
- 48.0%
- Debt / equity
- 0.92×
- Book value / share
- $34.23
- Revenue growth (YoY)
- 8.0%
- Net income growth (YoY)
- 38.4%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 5.15safe
- Accruals / assets
- −4.9%clean
- Beneish M-Score
- -2.56normal
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 6 good- Operating margin is positive
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Price T Rowe Associates Inc /Md/Passive (13G)May 15, 2026
- Vanguard Capital Management LlcPassive (13G)Apr 30, 2026
- Vanguard Portfolio Management LlcPassive (13G)Apr 29, 2026
- Vanguard Group IncPassive (13G)Mar 27, 2026
- Blackrock, Inc.Passive (13G)Feb 5, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 2.1M | 1.7 | -4.6% |
| Apr 30, 2026 | 2.2M | 1.8 | +7.3% |
| Apr 15, 2026 | 2.0M | 2.0 | +9.4% |
| Mar 31, 2026 | 1.8M | 1.3 | -18.4% |
| Mar 13, 2026 | 2.3M | 1.3 | -2.4% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsMay 19, 2026
- New financial obligationApr 23, 2026
- Shareholder voteMar 24, 2026
- Director / officer changeMar 13, 2026
- Results of operationsFeb 23, 2026
- Results of operationsNov 24, 2025
- Director / officer changeNov 20, 2025
- Regulation FD disclosureOct 20, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SDJun 1, 2026
- 4FORM 4May 28, 2026
- 4FORM 4May 20, 2026
- 8-KMay 19, 2026
- SCHEDULE 13G/AMay 15, 2026
- SCHEDULE 13GApr 30, 2026
- SCHEDULE 13GApr 29, 2026
- 8-KApr 23, 2026
- 4FORM 4Apr 1, 2026
- 144Mar 30, 2026
- SCHEDULE 13G/AMar 27, 2026
- 4FORM 4Mar 26, 2026
- 4FORM 4Mar 26, 2026
- 4FORM 4Mar 26, 2026
- 144Mar 24, 2026
Corporate family
Spun off from Agilent TechnologiesA · Nov 1, 2014
From the spin-off filings we track. Follow a company to walk its own history.
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.